Expression of MAGE-1 Gene by Esophageal Carcinomas

スポンサーリンク

概要

• 論文の詳細を見る
• 1995-08-31

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• FUJITA Hirofumi

  Japan Bioassay Research Center

• YAMANA Hideaki

  Department of Surgery, Kurume University School of Medicine

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka

• Itoh Kyogo

  久留米大学 医学部免疫学

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka Jpn

• SHICHIJO Shigeki

  Department of Immunology, Kurume University School of Medicine

• Itoh K

  Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy

• Itoh Kyogo

  Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen

• Itoh Kyogo

  Department Of Immunology

• Itoh Kyogo

  Department Of Lmmunology Kurume University School Of Medicine

• TOH Yuji

  First Department of Surgery, Kurume University School of Medicine

• YAMANA Hideaki

  First Department of Surgery, Kurume University School of Medicine

• FUJITA Hiromasa

  First Department of Surgery, Kurume University School of Medicine

• TOU Uhi

  First Department of Surgery, Kurume University School of Medicine

• SAKAGUCHI Minako

  Department of lmmunology, Kurume University School of Medicine

• KAKEGAWA Teruo

  First Department of Surgery, Kurume University School of Medicine

• Shichijo S

  Department Of Immunology Kurume University School Of Medicine

• Shichijo Shigeki

  Departments Of Immunology

• Itoh Kyogo

  Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University

• Yamana Hideaki

  Department Of Surgery Kurume University School Of Medicine

• Toh Uhi

  Department Of Surgery Kurume University School Of Medicine

• Kakegawa Teruo

  First Department Of Surgery Kurume University School Of Medicine

• Toh Yuji

  First Depertment Of Surgery Kurume University School Of Medicine

• Kakegawa T

  International Goodwill Hospital Kanagawa Jpn

• Shichijo Shigeki

  Department Of Immunology And Immunotherapy Kurume University School Of Medicine

• Sakaguchi Minako

  Department Of Lmmunology Kurume University School Of Medicine

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• β-Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Difference in Target Organs in Carcinogenesis with a Heterocyclic Amine, 2-Amino-3,4-dimethylimidazo[4,5-f]quinoline, in Different Strains of Mice
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Adenomyoepithelioma of the Breast Diagnosed by a Mammotome Biopsy : Report of a Case
• Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• The Effect of Radioimmunotherapy Using Murine Monoclonal Antibody KIS1 on Esophageal Squamous Cell Carcinoma-Bearing Nude Mice
• Anti-neutrophil cytoplasmic antibody for proteinase 3 in a child with polyarteritis nodosa
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• Left Partial Anomalous Pulmonary Venous Connection Found During a Lobectomy for Lung Cancer : Report of a Case
• Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging
• Long-term Survival after Three-field Lymphadenectomy for an Adenocarcinoma in Barrett's Esophagus with Metastasis to Virchow's Node
• Evaluation of an Aortic Stent Graft for Use in Surgery on Esophageal Cancer Involving the Thoracic Aorta : Experimental Study
• Spontaneous Regression in Small Cell Esophageal Carcinoma
• Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer
• Three-field Dissection for Squamous Cell Carcinoma in the Thoracic Esophagus
• The singnificance of telomerase activity in cancer lesions and the noncancerous epithelium of the esophagus
• Radical Esophagectomy and Secondary Anastomosis for High-Risk Patients With Intrathoracic Esophageal Carcinoma
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
• Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer
• Retrospective investigation of pulmonary resection in patients with high total pulmonary vascular resistance during preoperative unilateral pulmonary artery occlusion
• Selection of Pulmonary Resection Procedures to Avoid Postoperative Complications
• Expired Gas Analysis During Exercise Testing Pre-pneumonectomy
• Preoperative Spirometry Versus Expired Gas Analysis During Exercise Testing as Predictors of Cardiopulmonary Complications After Lung Resection
• Cervico-Thoraco-Abdominal (3-Field) Lymph Node Dissection for Carcinoma in the Thoracic Esophagus
• Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
• Questionable Resection for Carcinoma of the Esophagus Involving the Trachea, Bronchus and/or Aorta : A Comparative and Multivariate Analysis
• Preoperative Radiation for Carcinoma of the Thoracic Esophagus Involving Adjacent Organs : A Comparative and Multivariate Analysis of Prognosis
• Evaluation of the Cell Kinetics of MNNG-Treated Rat Gastric Mucosa Based on AgNOR and ODC Activity
• Selection of Pulmonary Resection Procedures to Reduce Postoperative Complications in 200 Patients
• Esophagectomy for Thoracic Esophageal Cancer with a Double Aortic Arch : Report of a Case
• Factors Related to an Early Restoration of Exercise Capacity After Major Lung Resection
• IS-I-1 THE PRESENT STATE OF SURGICAL TREATMENT FOR ESOPHAGEAL CARCINOMA
• Exploring immune therapy for renal cancer
• Giant Malignant Phyllodes Tumor: A Case Report
• Atypical endothelial cells with a number of filaments in growing blood vessels after gastro-gastrostomy.
• Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes
• Immunohistochemical Localization of Vascular Endothelial Growth Factor in Esophageal Cancer.
• Preoperative Prediction of Mortality Following Surgery for Esophageal Cancer.
• Clinical Aspects of Total Colectomy. Laparoscopic Versus Open Technique for Familial Adenomatous Polyposis and Ulcerative Colitis.:Laparoscopic Versus Open Technique for Familial Adenomatous Polyposis and Ulcerative Colitis
• Increase in the Capability of Interleukin 2 Gene-Transduced Renal Cell Carcinoma Cells to Induce Cytotoxic Lymphocytes.
• Comparison between Natural and Immunized Anti-GM1 Antibodies Analyzed by Marker Releasing Rate Assay with Liposome.
• Function Outcome of Double-Stapled and Transanal Ileal Pouch-Anal Anastomosis after Proctocolectomy.
• Pulmonary Capacity in Lung Cancer Patients Prior to Lung Resection. Comparison of the Unilateral Pulmonary Artery Occlusion Test with Expired Gas Analysis during Exercise Testing.:Comparison of the Unilateral Pulmonary Artery Occlusion Test with Expired G
• Gastric operations in patients with hepatic cirrhosis following endoscopic sclerotherapy.
• Zero Operative Mortality for Gastric Cancer with Hepatic Cirrhosis.
• Vagotomy and acid secretion.
• Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer

もっと見る 閉じる

スポンサーリンク